Review



tnf α production by elisa  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    R&D Systems tnf α production by elisa
    Novel human IgG4 antibodies 3D7, 8G10, and 8H1 recognize TLR4 and MD2 while 7D11 recognizes only MD2. Detection of recombinant TLR4/MD2 heterodimer (a) TLR4 alone (b) or MD2 alone (c) by <t>ELISA</t> using a 3-fold dilution series of human IgG4 antibodies 3D7, 8G10, 8H1, and 7D11. With the concentration of TLR4Ab held constant, an increasing concentration of soluble TLR4 was added in the ELISA assay to compete with the plate bound TLR4/MD2 (d). Data represents a single experiment in duplicate.
    Tnf α Production By Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 681 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tnf+%CE%B1+production+by+elisa/pmc12143713-275-10-14?v=R%26D+Systems
    Average 97 stars, based on 681 article reviews
    tnf α production by elisa - by Bioz Stars, 2026-08
    97/100 stars

    Images

    1) Product Images from "Higher order receptor clustering due to the IgG3 subclass is necessary for TLR4 signaling and tolerance induction by novel human anti-TLR4 antibodies"

    Article Title: Higher order receptor clustering due to the IgG3 subclass is necessary for TLR4 signaling and tolerance induction by novel human anti-TLR4 antibodies

    Journal: mAbs

    doi: 10.1080/19420862.2025.2515415

    Novel human IgG4 antibodies 3D7, 8G10, and 8H1 recognize TLR4 and MD2 while 7D11 recognizes only MD2. Detection of recombinant TLR4/MD2 heterodimer (a) TLR4 alone (b) or MD2 alone (c) by ELISA using a 3-fold dilution series of human IgG4 antibodies 3D7, 8G10, 8H1, and 7D11. With the concentration of TLR4Ab held constant, an increasing concentration of soluble TLR4 was added in the ELISA assay to compete with the plate bound TLR4/MD2 (d). Data represents a single experiment in duplicate.
    Figure Legend Snippet: Novel human IgG4 antibodies 3D7, 8G10, and 8H1 recognize TLR4 and MD2 while 7D11 recognizes only MD2. Detection of recombinant TLR4/MD2 heterodimer (a) TLR4 alone (b) or MD2 alone (c) by ELISA using a 3-fold dilution series of human IgG4 antibodies 3D7, 8G10, 8H1, and 7D11. With the concentration of TLR4Ab held constant, an increasing concentration of soluble TLR4 was added in the ELISA assay to compete with the plate bound TLR4/MD2 (d). Data represents a single experiment in duplicate.

    Techniques Used: Recombinant, Enzyme-linked Immunosorbent Assay, Concentration Assay

    IgG3 TV-7D11 induces tolerance in primary human myeloid cells. Human CD14+ monocytes were purified by magnetic bead negative selection. 1 × 10^6 cells/well were seeded in 24-well plates and stimulated with IgG3 8H1 (10 μg/ml), IgG3 TV-7D11 (10 μg/ml), or LPS (.01 μg/ml). After 24 h supernatants were removed and tested for TNF-α by ELISA (a), followed by addition of fresh media and culture for 5 d to allow cells to return to a resting state (b). On day 6, cells were split into 96-well plates at 50,000 cells/well and allowed to rest for 24 h prior to re-challenge with LPS at .01 μg/ml. Supernatants were again collected at 24 h and assayed for TNF-α production by ELISA (c). Data points represent three individuals from two independent experiments. Statistical analysis by ANOVA * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
    Figure Legend Snippet: IgG3 TV-7D11 induces tolerance in primary human myeloid cells. Human CD14+ monocytes were purified by magnetic bead negative selection. 1 × 10^6 cells/well were seeded in 24-well plates and stimulated with IgG3 8H1 (10 μg/ml), IgG3 TV-7D11 (10 μg/ml), or LPS (.01 μg/ml). After 24 h supernatants were removed and tested for TNF-α by ELISA (a), followed by addition of fresh media and culture for 5 d to allow cells to return to a resting state (b). On day 6, cells were split into 96-well plates at 50,000 cells/well and allowed to rest for 24 h prior to re-challenge with LPS at .01 μg/ml. Supernatants were again collected at 24 h and assayed for TNF-α production by ELISA (c). Data points represent three individuals from two independent experiments. Statistical analysis by ANOVA * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Techniques Used: Purification, Selection, Enzyme-linked Immunosorbent Assay



    Similar Products

    94
    Elabscience Biotechnology tnf α production assay
    Tnf α Production Assay, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tnf+%CE%B1+production+by+elisa/10__5530_slash_ctbp__2026__1__8-60-0-11?v=Elabscience+Biotechnology
    Average 94 stars, based on 1 article reviews
    tnf α production assay - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    96
    Proteintech tnf α production
    Tnf α Production, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tnf+%CE%B1+production+by+elisa/pm41109047-110-3-10?v=Proteintech
    Average 96 stars, based on 1 article reviews
    tnf α production - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    97
    R&D Systems tnf α production by elisa
    Novel human IgG4 antibodies 3D7, 8G10, and 8H1 recognize TLR4 and MD2 while 7D11 recognizes only MD2. Detection of recombinant TLR4/MD2 heterodimer (a) TLR4 alone (b) or MD2 alone (c) by <t>ELISA</t> using a 3-fold dilution series of human IgG4 antibodies 3D7, 8G10, 8H1, and 7D11. With the concentration of TLR4Ab held constant, an increasing concentration of soluble TLR4 was added in the ELISA assay to compete with the plate bound TLR4/MD2 (d). Data represents a single experiment in duplicate.
    Tnf α Production By Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tnf+%CE%B1+production+by+elisa/pmc12143713-275-10-14?v=R%26D+Systems
    Average 97 stars, based on 1 article reviews
    tnf α production by elisa - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    96
    Elabscience Biotechnology product numbers
    Novel human IgG4 antibodies 3D7, 8G10, and 8H1 recognize TLR4 and MD2 while 7D11 recognizes only MD2. Detection of recombinant TLR4/MD2 heterodimer (a) TLR4 alone (b) or MD2 alone (c) by <t>ELISA</t> using a 3-fold dilution series of human IgG4 antibodies 3D7, 8G10, 8H1, and 7D11. With the concentration of TLR4Ab held constant, an increasing concentration of soluble TLR4 was added in the ELISA assay to compete with the plate bound TLR4/MD2 (d). Data represents a single experiment in duplicate.
    Product Numbers, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tnf+%CE%B1+production+by+elisa/pmc12184616-107-38-45?v=Elabscience+Biotechnology
    Average 96 stars, based on 1 article reviews
    product numbers - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    93
    R&D Systems tumor necrosis factor α tnf α production
    Novel human IgG4 antibodies 3D7, 8G10, and 8H1 recognize TLR4 and MD2 while 7D11 recognizes only MD2. Detection of recombinant TLR4/MD2 heterodimer (a) TLR4 alone (b) or MD2 alone (c) by <t>ELISA</t> using a 3-fold dilution series of human IgG4 antibodies 3D7, 8G10, 8H1, and 7D11. With the concentration of TLR4Ab held constant, an increasing concentration of soluble TLR4 was added in the ELISA assay to compete with the plate bound TLR4/MD2 (d). Data represents a single experiment in duplicate.
    Tumor Necrosis Factor α Tnf α Production, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tnf+%CE%B1+production+by+elisa/pm38710903-80-23-41?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    tumor necrosis factor α tnf α production - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    96
    R&D Systems followup product hsta00e
    Novel human IgG4 antibodies 3D7, 8G10, and 8H1 recognize TLR4 and MD2 while 7D11 recognizes only MD2. Detection of recombinant TLR4/MD2 heterodimer (a) TLR4 alone (b) or MD2 alone (c) by <t>ELISA</t> using a 3-fold dilution series of human IgG4 antibodies 3D7, 8G10, 8H1, and 7D11. With the concentration of TLR4Ab held constant, an increasing concentration of soluble TLR4 was added in the ELISA assay to compete with the plate bound TLR4/MD2 (d). Data represents a single experiment in duplicate.
    Followup Product Hsta00e, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tnf+%CE%B1+production+by+elisa/pm38142424-54-1-4?v=R%26D+Systems
    Average 96 stars, based on 1 article reviews
    followup product hsta00e - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    95
    R&D Systems tumor necrosis factor alpha tnf α production
    FIGURE 2 VG161 enhances the immune response in breast cancer. (A–C) MCF‐7 cells or MDA‐MB‐231 and SK‐BR‐3 cells were infected with VG161 at a multiplicity of infection of 0.5 or 1 for the indicated times. Human IL‐12p70, IL‐15, and IgG4 secretion levels were measured by enzyme‐linked immunosorbent assays (ELISAs). Then, 50 × 104 EMT‐6 cells were subcutaneously implanted into the second mammary fat pad of both sides of BALB/c mice to establish an orthotopic transplantation model. Tumor‐bearing mice were infected intratumorally with either vehicle (PBS) or 1 × 107 PFU of mVG161 virus on the right side (n = 8 mice per group). Both right and left side tumors were harvested 120 h after the final injection. (D) RNA was isolated and purified followed by library construction and sequencing performed on the BGISEQ‐500 platform by Wuhan Genomic Institution. KEGG analysis of immunostimulatory pathway activation was performed in each group. (E) The mRNA levels of relevant genes <t>in</t> <t>TNF</t> and IL‐17 pathway were measured by RT‐qPCR. (F−G) Mouse serum was collected 120 h after the final injection, then mouse IFN‐γ and TNF‐α levels were assessed by ELISAs. The levels of serum BUN, creatinine, UA, AST, GGT, and ALT were analyzed using the AU680 Chemistry System. (H) Immunohistochemical analysis of CD3+, CD4+, and CD8+ cells was performed on tumor sections. Scale bar = 100 μm. Data are represented as the mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001. SD, standard deviation.
    Tumor Necrosis Factor Alpha Tnf α Production, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tnf+%CE%B1+production+by+elisa/pm37212336-51-9-24?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    tumor necrosis factor alpha tnf α production - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    97
    R&D Systems product no
    FIGURE 2 VG161 enhances the immune response in breast cancer. (A–C) MCF‐7 cells or MDA‐MB‐231 and SK‐BR‐3 cells were infected with VG161 at a multiplicity of infection of 0.5 or 1 for the indicated times. Human IL‐12p70, IL‐15, and IgG4 secretion levels were measured by enzyme‐linked immunosorbent assays (ELISAs). Then, 50 × 104 EMT‐6 cells were subcutaneously implanted into the second mammary fat pad of both sides of BALB/c mice to establish an orthotopic transplantation model. Tumor‐bearing mice were infected intratumorally with either vehicle (PBS) or 1 × 107 PFU of mVG161 virus on the right side (n = 8 mice per group). Both right and left side tumors were harvested 120 h after the final injection. (D) RNA was isolated and purified followed by library construction and sequencing performed on the BGISEQ‐500 platform by Wuhan Genomic Institution. KEGG analysis of immunostimulatory pathway activation was performed in each group. (E) The mRNA levels of relevant genes <t>in</t> <t>TNF</t> and IL‐17 pathway were measured by RT‐qPCR. (F−G) Mouse serum was collected 120 h after the final injection, then mouse IFN‐γ and TNF‐α levels were assessed by ELISAs. The levels of serum BUN, creatinine, UA, AST, GGT, and ALT were analyzed using the AU680 Chemistry System. (H) Immunohistochemical analysis of CD3+, CD4+, and CD8+ cells was performed on tumor sections. Scale bar = 100 μm. Data are represented as the mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001. SD, standard deviation.
    Product No, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tnf+%CE%B1+production+by+elisa/pm36880658-147-17-45?v=R%26D+Systems
    Average 97 stars, based on 1 article reviews
    product no - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    90
    Boster Bio elisa kits analysis il-6, il-1β, nos2 tnf-α production
    FIGURE 2 VG161 enhances the immune response in breast cancer. (A–C) MCF‐7 cells or MDA‐MB‐231 and SK‐BR‐3 cells were infected with VG161 at a multiplicity of infection of 0.5 or 1 for the indicated times. Human IL‐12p70, IL‐15, and IgG4 secretion levels were measured by enzyme‐linked immunosorbent assays (ELISAs). Then, 50 × 104 EMT‐6 cells were subcutaneously implanted into the second mammary fat pad of both sides of BALB/c mice to establish an orthotopic transplantation model. Tumor‐bearing mice were infected intratumorally with either vehicle (PBS) or 1 × 107 PFU of mVG161 virus on the right side (n = 8 mice per group). Both right and left side tumors were harvested 120 h after the final injection. (D) RNA was isolated and purified followed by library construction and sequencing performed on the BGISEQ‐500 platform by Wuhan Genomic Institution. KEGG analysis of immunostimulatory pathway activation was performed in each group. (E) The mRNA levels of relevant genes <t>in</t> <t>TNF</t> and IL‐17 pathway were measured by RT‐qPCR. (F−G) Mouse serum was collected 120 h after the final injection, then mouse IFN‐γ and TNF‐α levels were assessed by ELISAs. The levels of serum BUN, creatinine, UA, AST, GGT, and ALT were analyzed using the AU680 Chemistry System. (H) Immunohistochemical analysis of CD3+, CD4+, and CD8+ cells was performed on tumor sections. Scale bar = 100 μm. Data are represented as the mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001. SD, standard deviation.
    Elisa Kits Analysis Il 6, Il 1β, Nos2 Tnf α Production, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tnf+%CE%B1+production+by+elisa/pm35718151-52-8-15?v=Boster+Bio
    Average 90 stars, based on 1 article reviews
    elisa kits analysis il-6, il-1β, nos2 tnf-α production - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results


    Novel human IgG4 antibodies 3D7, 8G10, and 8H1 recognize TLR4 and MD2 while 7D11 recognizes only MD2. Detection of recombinant TLR4/MD2 heterodimer (a) TLR4 alone (b) or MD2 alone (c) by ELISA using a 3-fold dilution series of human IgG4 antibodies 3D7, 8G10, 8H1, and 7D11. With the concentration of TLR4Ab held constant, an increasing concentration of soluble TLR4 was added in the ELISA assay to compete with the plate bound TLR4/MD2 (d). Data represents a single experiment in duplicate.

    Journal: mAbs

    Article Title: Higher order receptor clustering due to the IgG3 subclass is necessary for TLR4 signaling and tolerance induction by novel human anti-TLR4 antibodies

    doi: 10.1080/19420862.2025.2515415

    Figure Lengend Snippet: Novel human IgG4 antibodies 3D7, 8G10, and 8H1 recognize TLR4 and MD2 while 7D11 recognizes only MD2. Detection of recombinant TLR4/MD2 heterodimer (a) TLR4 alone (b) or MD2 alone (c) by ELISA using a 3-fold dilution series of human IgG4 antibodies 3D7, 8G10, 8H1, and 7D11. With the concentration of TLR4Ab held constant, an increasing concentration of soluble TLR4 was added in the ELISA assay to compete with the plate bound TLR4/MD2 (d). Data represents a single experiment in duplicate.

    Article Snippet: Supernatants were again collected at 24 h and assayed for TNF-α production by ELISA (R&D Systems, #DY210–05).

    Techniques: Recombinant, Enzyme-linked Immunosorbent Assay, Concentration Assay

    IgG3 TV-7D11 induces tolerance in primary human myeloid cells. Human CD14+ monocytes were purified by magnetic bead negative selection. 1 × 10^6 cells/well were seeded in 24-well plates and stimulated with IgG3 8H1 (10 μg/ml), IgG3 TV-7D11 (10 μg/ml), or LPS (.01 μg/ml). After 24 h supernatants were removed and tested for TNF-α by ELISA (a), followed by addition of fresh media and culture for 5 d to allow cells to return to a resting state (b). On day 6, cells were split into 96-well plates at 50,000 cells/well and allowed to rest for 24 h prior to re-challenge with LPS at .01 μg/ml. Supernatants were again collected at 24 h and assayed for TNF-α production by ELISA (c). Data points represent three individuals from two independent experiments. Statistical analysis by ANOVA * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Journal: mAbs

    Article Title: Higher order receptor clustering due to the IgG3 subclass is necessary for TLR4 signaling and tolerance induction by novel human anti-TLR4 antibodies

    doi: 10.1080/19420862.2025.2515415

    Figure Lengend Snippet: IgG3 TV-7D11 induces tolerance in primary human myeloid cells. Human CD14+ monocytes were purified by magnetic bead negative selection. 1 × 10^6 cells/well were seeded in 24-well plates and stimulated with IgG3 8H1 (10 μg/ml), IgG3 TV-7D11 (10 μg/ml), or LPS (.01 μg/ml). After 24 h supernatants were removed and tested for TNF-α by ELISA (a), followed by addition of fresh media and culture for 5 d to allow cells to return to a resting state (b). On day 6, cells were split into 96-well plates at 50,000 cells/well and allowed to rest for 24 h prior to re-challenge with LPS at .01 μg/ml. Supernatants were again collected at 24 h and assayed for TNF-α production by ELISA (c). Data points represent three individuals from two independent experiments. Statistical analysis by ANOVA * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Article Snippet: Supernatants were again collected at 24 h and assayed for TNF-α production by ELISA (R&D Systems, #DY210–05).

    Techniques: Purification, Selection, Enzyme-linked Immunosorbent Assay

    FIGURE 2 VG161 enhances the immune response in breast cancer. (A–C) MCF‐7 cells or MDA‐MB‐231 and SK‐BR‐3 cells were infected with VG161 at a multiplicity of infection of 0.5 or 1 for the indicated times. Human IL‐12p70, IL‐15, and IgG4 secretion levels were measured by enzyme‐linked immunosorbent assays (ELISAs). Then, 50 × 104 EMT‐6 cells were subcutaneously implanted into the second mammary fat pad of both sides of BALB/c mice to establish an orthotopic transplantation model. Tumor‐bearing mice were infected intratumorally with either vehicle (PBS) or 1 × 107 PFU of mVG161 virus on the right side (n = 8 mice per group). Both right and left side tumors were harvested 120 h after the final injection. (D) RNA was isolated and purified followed by library construction and sequencing performed on the BGISEQ‐500 platform by Wuhan Genomic Institution. KEGG analysis of immunostimulatory pathway activation was performed in each group. (E) The mRNA levels of relevant genes in TNF and IL‐17 pathway were measured by RT‐qPCR. (F−G) Mouse serum was collected 120 h after the final injection, then mouse IFN‐γ and TNF‐α levels were assessed by ELISAs. The levels of serum BUN, creatinine, UA, AST, GGT, and ALT were analyzed using the AU680 Chemistry System. (H) Immunohistochemical analysis of CD3+, CD4+, and CD8+ cells was performed on tumor sections. Scale bar = 100 μm. Data are represented as the mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001. SD, standard deviation.

    Journal: Journal of medical virology

    Article Title: Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy.

    doi: 10.1002/jmv.28768

    Figure Lengend Snippet: FIGURE 2 VG161 enhances the immune response in breast cancer. (A–C) MCF‐7 cells or MDA‐MB‐231 and SK‐BR‐3 cells were infected with VG161 at a multiplicity of infection of 0.5 or 1 for the indicated times. Human IL‐12p70, IL‐15, and IgG4 secretion levels were measured by enzyme‐linked immunosorbent assays (ELISAs). Then, 50 × 104 EMT‐6 cells were subcutaneously implanted into the second mammary fat pad of both sides of BALB/c mice to establish an orthotopic transplantation model. Tumor‐bearing mice were infected intratumorally with either vehicle (PBS) or 1 × 107 PFU of mVG161 virus on the right side (n = 8 mice per group). Both right and left side tumors were harvested 120 h after the final injection. (D) RNA was isolated and purified followed by library construction and sequencing performed on the BGISEQ‐500 platform by Wuhan Genomic Institution. KEGG analysis of immunostimulatory pathway activation was performed in each group. (E) The mRNA levels of relevant genes in TNF and IL‐17 pathway were measured by RT‐qPCR. (F−G) Mouse serum was collected 120 h after the final injection, then mouse IFN‐γ and TNF‐α levels were assessed by ELISAs. The levels of serum BUN, creatinine, UA, AST, GGT, and ALT were analyzed using the AU680 Chemistry System. (H) Immunohistochemical analysis of CD3+, CD4+, and CD8+ cells was performed on tumor sections. Scale bar = 100 μm. Data are represented as the mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001. SD, standard deviation.

    Article Snippet: Mice serum was analyzed for Interferon gamma (IFN‐γ) and Tumor Necrosis Factor alpha (TNF‐α) production using the IFN‐γ and TNF‐α Mouse DuoSet ELISA Kit (R&D Systems) according to the manufacturer's recommended procedures.

    Techniques: Infection, Transplantation Assay, Virus, Injection, Isolation, Purification, Sequencing, Activation Assay, Quantitative RT-PCR, Immunohistochemical staining, Standard Deviation

    FIGURE 5 VG161 treatment followed by cotreatment with Paclitaxel (PTX) greatly alters the tumor microenvironment (TME). To establish an orthotopic transplantation model, 50 × 104 EMT‐6 cells were subcutaneously implanted into the second mammary fat pad of right side of BALB/c mice. Tumor‐bearing mice were treated with PBS, 1 × 107 PFU of mVG161, PTX (25 mg/kg), or mVG161 + PTX. Tumors were treated with mVG161 for three consecutive days. PTX treatments were every other day for two injections. Tumors were harvested 120 h after the final injection. (A–B) The percentages of different subsets of lymphoid cells, including CD8+ T cells and natural killer cells (NKs) (which expressed IFN‐γ, TNF‐α, and CD107a), and myeloid cells, including m‐MDSCs (which expressed CD11b+/Ly6C+) and DC cells (which expressed MHCII+

    Journal: Journal of medical virology

    Article Title: Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy.

    doi: 10.1002/jmv.28768

    Figure Lengend Snippet: FIGURE 5 VG161 treatment followed by cotreatment with Paclitaxel (PTX) greatly alters the tumor microenvironment (TME). To establish an orthotopic transplantation model, 50 × 104 EMT‐6 cells were subcutaneously implanted into the second mammary fat pad of right side of BALB/c mice. Tumor‐bearing mice were treated with PBS, 1 × 107 PFU of mVG161, PTX (25 mg/kg), or mVG161 + PTX. Tumors were treated with mVG161 for three consecutive days. PTX treatments were every other day for two injections. Tumors were harvested 120 h after the final injection. (A–B) The percentages of different subsets of lymphoid cells, including CD8+ T cells and natural killer cells (NKs) (which expressed IFN‐γ, TNF‐α, and CD107a), and myeloid cells, including m‐MDSCs (which expressed CD11b+/Ly6C+) and DC cells (which expressed MHCII+

    Article Snippet: Mice serum was analyzed for Interferon gamma (IFN‐γ) and Tumor Necrosis Factor alpha (TNF‐α) production using the IFN‐γ and TNF‐α Mouse DuoSet ELISA Kit (R&D Systems) according to the manufacturer's recommended procedures.

    Techniques: Transplantation Assay, Injection

    FIGURE 6 Schematic depicting the effect of VG161 and Paclitaxel (PTX) in breast cancer (BC). Combining the VG161 oncolytic herpesvirus with PTX can significantly repress BC tumor growth and reduce metastatic pulmonary lesions. Additionally, this combination alters the tumor microenvironment, which is associated with the infiltration of lymphoid cells, including CD4+ T cells, CD8+ T cells, and natural killer cells (expressing TNF‐α and IFN‐γ) and myeloid cells including macrophages, m‐MDSCs, and DC cells. DC, dendritic cell; m‐MDSCs, myeloid‐derived suppressor cells; SD, standard deviation.

    Journal: Journal of medical virology

    Article Title: Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy.

    doi: 10.1002/jmv.28768

    Figure Lengend Snippet: FIGURE 6 Schematic depicting the effect of VG161 and Paclitaxel (PTX) in breast cancer (BC). Combining the VG161 oncolytic herpesvirus with PTX can significantly repress BC tumor growth and reduce metastatic pulmonary lesions. Additionally, this combination alters the tumor microenvironment, which is associated with the infiltration of lymphoid cells, including CD4+ T cells, CD8+ T cells, and natural killer cells (expressing TNF‐α and IFN‐γ) and myeloid cells including macrophages, m‐MDSCs, and DC cells. DC, dendritic cell; m‐MDSCs, myeloid‐derived suppressor cells; SD, standard deviation.

    Article Snippet: Mice serum was analyzed for Interferon gamma (IFN‐γ) and Tumor Necrosis Factor alpha (TNF‐α) production using the IFN‐γ and TNF‐α Mouse DuoSet ELISA Kit (R&D Systems) according to the manufacturer's recommended procedures.

    Techniques: Expressing, Derivative Assay, Standard Deviation